In terms of documented efficacy, this is not a close comparison: GLP-1 S has shown weight reductions in the range of 13-20% of body weight in clinical trials, while AOD-9604s pivotal trial failed to demonstrate a significant effect at that scale
Published in the New England Journal of Medicine in 2025, this Phase 3 study enrolled 610 Chinese adults with obesity or overweight accompanied by at least one weight-related comorbidity
In clinical trials, participants lost up to 28.7% of their body weight
Seasonal Considerations for Canadian Users Canadian winters introduce some practical factors that year-round Retatrutide users should think about
Sterile water evaporates faster and does not contain the preservative (benzyl alcohol) that keeps your solution safe for multiple uses
PlexusDx offers both injectable and oral formulations, including compounded semaglutide injection ($189/mo), oral semaglutide ($289/mo month-to-month, or from $249/mo on the 6-month plan), and tirzepatide options ($279/mo depending on delivery method)